Investigation into Trump Uncovers 1,000 More Stock Trades, Including Investments in Firms Tied to Iran War
WASHINGTON-- President Donald Trump has disclosed more than 1,000 additional stock transactions made in June, extending a remarkable level of trading activity during his presidency and intensifying questions about the potential for his personal finances to intersect with decisions made by his administration.
The transactions were detailed in a financial disclosure filed with the Office of Government Ethics. The filing shows Trump bought and sold thousands of dollars worth of shares in companies operating in sectors directly affected by the administration’s policies, including energy companies that could be influenced by developments surrounding the war in Iran.
The latest disclosure adds to a growing record of investment activity by Trump while he occupies the White House. Rather than limiting his exposure to individual companies and industries affected by federal policy, the filings show investments spread across a broad range of businesses.
Among the companies appearing in the disclosures are major pharmaceutical manufacturers, including Eli Lilly and Merck, as well as technology companies such as Nvidia, one of the world's most prominent producers of advanced artificial intelligence chips.
Those investments are notable because the Trump administration has pursued policies that could have significant consequences for the pharmaceutical, technology and energy industries. The administration has sought to reshape drug pricing, accelerate U.S. leadership in artificial intelligence and expand domestic energy production while imposing policies affecting international energy markets.
The White House has rejected any suggestion that Trump personally controls the timing or substance of the trades.
White House spokesman Davis Ingle said in a statement that Trump's investment portfolio “is independently managed by third-party financial institutions.” He said neither Trump nor members of his family have the ability to instruct the managers about which securities to buy or sell.
“Neither President Trump nor any member of his family has any ability to direct, influence, or provide input regarding how the portfolio is invested or when investments are being bought or sold,” Ingle said. “There are no conflicts of interest.”
The administration's explanation has not ended criticism from congressional Democrats and government ethics advocates, who argue that the sheer volume of transactions creates the appearance of potential conflicts even if Trump does not personally order individual trades.
The issue has drawn particular attention because Trump's financial interests span industries that are routinely affected by presidential decisions, federal regulations, tariffs, military operations and other government actions.
Critics say the unprecedented scale of the trading makes it difficult for the public to determine whether Trump's financial interests could benefit from policy decisions made by his administration. They also contend that the president's continued ownership of a substantial and diverse portfolio creates a higher level of potential exposure than the arrangements traditionally used by presidents seeking to separate their personal finances from government responsibilities.
The latest filing is only part of a much larger picture of Trump's financial activity since returning to the White House.
Previous disclosures have shown Trump receiving billions of dollars in reported income and holdings tied to cryptocurrency ventures, licensing and royalty arrangements, real estate and other investments. His financial interests have expanded as his business empire has continued operating while he serves as president.
That level of personal financial activity stands in contrast with the approach taken by many previous presidents, who generally attempted to reduce potential conflicts by placing assets in blind trusts or otherwise separating themselves from decisions involving specific investments.
Federal law does not require the president to place assets in a blind trust, and Trump's administration maintains that independent management of his portfolio prevents him from influencing individual investment decisions.
Nevertheless, ethics experts and political opponents have continued to scrutinize the disclosures, particularly when Trump's holdings involve companies whose industries are affected by major policy decisions made by the administration.
The June transactions underscore the unusual financial circumstances surrounding Trump's second term. With thousands of individual trades disclosed over the course of the year and investments spanning some of the country's most strategically important industries, questions about presidential wealth, transparency and potential conflicts are likely to remain a focus of public debate.
For critics, the central issue is not simply whether Trump personally directed any particular transaction, but whether a sitting president should maintain such extensive financial exposure to companies and industries that can be materially affected by decisions made from the Oval Office.